A Case of SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis

被引：0
|
作者：
Rao, Shiavax J. [1 ]
Kumar, Kaushik [1 ]
Saleh, Nahar [1 ]
机构：
[1] MedStar Union Mem Hosp, Internal Med, Baltimore, MD 21218 USA
来源：
CUREUS JOURNAL OF MEDICAL SCIENCE | 2022年 / 14卷 / 10期
关键词：
high anion gap metabolic acidosis; sglt-2; inhibitor; euglycemic dka; diabetic keto acidosis; sodium-glucose cotransporter-2 inhibitors;
D O I：
10.7759/cureus.30106
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
While rare, serious adverse effects including euglycemic diabetic ketoacidosis (EDKA) have been associated with sodium-glucose cotransporter-2 inhibitor (SGLT2i) use. We present an interesting case of SGLT2i-induced EDKA occurring two years after initiation of therapy. Most patients with EDKA recover with prompt recognition and treatment. Patient education about identifying early signs remains a cornerstone of early identification and response to SGLT2i-induced EDKA.
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Nephrology Consultation for Severe SGLT2 Inhibitor-Induced Ketoacidosis in Type 2 Diabetes: Case Report
    Nappi, Felice
    La Verde, Antonietta
    Carfora, Giovanni
    Garofalo, Carlo
    Provenzano, Michele
    Sasso, Ferdinando Carlo
    De Nicola, Luca
    MEDICINA-LITHUANIA, 2019, 55 (08):
  • [22] Melatonin ameliorates SGLT2 inhibitor-induced diabetic ketoacidosis by inhibiting lipolysis and hepatic ketogenesis in type 2 diabetic mice
    Park, Jae-Hyung
    Seo, Incheol
    Shim, Hae-Min
    Cho, Hochan
    JOURNAL OF PINEAL RESEARCH, 2020, 68 (02)
  • [23] Severe SGLT-2 inhibitor-induced euglycemic ketoacidosis-a rare but serious complication
    Rotsel, E.
    Pietsch, U.
    ANAESTHESIST, 2020, 69 (01): : 49 - 51
  • [24] A CASE REPORT AND LITERATURE REVIEW OF SGLT2 INHIBITOR-ASSOCIATED EUGLYCEMIC DIABETIC KETOACIDOSIS AFTER BARIATRIC SURGERY
    Kapila, Vaishali
    Topf, Joel
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 77 (04) : 610 - 611
  • [25] Prolonged Postoperative Euglycemic Diabetic Ketoacidosis in a Lung Transplant Recipient With Preoperative SGLT2 Inhibitor Use
    Choi, Christine H.
    Singh, Shivani
    Cheung, Albert T.
    Vanneman, Matthew
    Madhok, Jai
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2024, 38 (07) : 1539 - 1542
  • [26] COVID-19-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes on SGLT2 inhibitor: a case report
    Daniel Valente Batista
    Carla Antoniana Ferreira de Almeida Vieira
    Thomaz Alexandre Costa
    Eduardo Gomes Lima
    Diabetology International, 2021, 12 : 313 - 316
  • [27] From Sweet to Sour: SGLT-2-Inhibitor-Induced Euglycemic Diabetic Ketoacidosis
    Koceva, Andrijana
    Kravos Tramsek, Nika Aleksandra
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (07):
  • [28] COVID-19-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes on SGLT2 inhibitor: a case report
    Batista, Daniel Valente
    Ferreira de Almeida Vieira, Carla Antoniana
    Costa, Thomaz Alexandre
    Lima, Eduardo Gomes
    DIABETOLOGY INTERNATIONAL, 2021, 12 (03) : 313 - 316
  • [29] Sodium-glucose cotransporter-2 inhibitor-induced euglycemic diabetic ketoacidosis: A case report
    Han, Jingjing
    Xie, Shuo
    Jiao, Hongmei
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (09) : 1482 - 1485
  • [30] Euglycemic diabetic ketoacidosis related to SGLT2 inhibitor use in a patient with cobalamin C deficiency and diabetes
    Kamoun, Camilla
    Gold, Jessica
    Cuddapah, Sanmati
    Yudkoff, Marc
    McCormack, Shona
    HORMONE RESEARCH IN PAEDIATRICS, 2020, 93 : 80 - 81
12345